Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3579]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
Vaccination to improve the persistence of CD19 CAR T cells in relapsed ALL
Dr Sara Ghorashian - University College London, London, UK
Vaccination to improve the persistence of CD19 CAR T cells in relapsed ALL ( Dr Sara Ghorashian - University College London, London, UK )
23 Sep 2016
Developments in checkpoint immunotherapy
Dr James Larkin - The Royal Marsden NHS Foundation Trust, London, UK
Developments in checkpoint immunotherapy ( Dr James Larkin - The Royal Marsden NHS Foundation Trust, London, UK )
22 Sep 2016
Targetted medicine to reduce melanoma mutational burden
Prof Grant McArthur - The Royal Melbourne Hospital, Melbourne, Australia
Targetted medicine to reduce melanoma mutational burden ( Prof Grant McArthur - The Royal Melbourne Hospital, Melbourne, Australia )
22 Sep 2016
VISMO trial to treat basal cell carcinoma
Prof Axel Hauschild - University of Kiel, Kiel, Germany
VISMO trial to treat basal cell carcinoma ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )
22 Sep 2016
Checkpoint inhibitor therapy for treating melanoma
Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA
Checkpoint inhibitor therapy for treating melanoma ( Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA )
22 Sep 2016
Tumour heterogeneity and the impact on patient care
Dr Nicholas McGranahan - The Francis Crick Institute, London, UK
Tumour heterogeneity and the impact on patient care ( Dr Nicholas McGranahan - The Francis Crick Institute, London, UK )
14 Sep 2016
Understanding the mechanisms of immunotherapy in lung cancer
Dr Rafael Rosell - Catalan Institute of Oncology, Barcelona, Spain
Understanding the mechanisms of immunotherapy in lung cancer ( Dr Rafael Rosell - Catalan Institute of Oncology, Barcelona, Spain )
14 Sep 2016
PDL1 and other biomarkers for selecting patients for immune checkpoint therapies
Dr Mary O'Brien - The Royal Marsden NHS Foundation Trust, London, UK
PDL1 and other biomarkers for selecting patients for immune checkpoint therapies ( Dr Mary O'Brien - The Royal Marsden NHS Foundation Trust, London, UK )
14 Sep 2016
Editor's Choice for August 2016
Prof Gordon McVie - Editor in Chief, ecancer
Editor's Choice for August 2016 ( Prof Gordon McVie - Editor in Chief, ecancer )
22 Aug 2016
Summary of developments in oesophageal and gastric cancers
Dr Caio Max Rocha Lima - Gibbs Cancer Center & Research Institute, Spartanburg...
Summary of developments in oesophageal and gastric cancers ( Dr Caio Max Rocha Lima - Gibbs Cancer Center & Research Institute, Spartanburg, South Carolina, USA )
26 Jul 2016
Updates in prostate and bladder cancer therapy
Prof Daniel Petrylak - Yale Cancer Center, New Haven, USA
Updates in prostate and bladder cancer therapy ( Prof Daniel Petrylak - Yale Cancer Center, New Haven, USA )
25 Jul 2016
Lung cancer immunotherapy
Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA
Lung cancer immunotherapy ( Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA )
25 Jul 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation